Health Care [ 8/12 ] | Biotechnology [ 36/76 ]
NASDAQ | Common Stock
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.
The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline.
Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 12, 24 | 0.18 Increased by +112.24% | -0.45 Increased by +140.00% |
| May 15, 24 | -0.14 Increased by +91.19% | -0.45 Increased by +68.89% |
| Mar 26, 24 | -0.62 Increased by +62.20% | -0.59 Decreased by -5.08% |
| Nov 13, 23 | -4.89 Decreased by -552.00% | -0.92 Decreased by -431.52% |
| Aug 14, 23 | -1.47 Decreased by -96.00% | -1.60 Increased by +8.13% |
| May 15, 23 | -1.59 Increased by +20.50% | -1.75 Increased by +9.14% |
| Mar 30, 23 | -1.64 Increased by +88.29% | -1.44 Decreased by -13.89% |
| Nov 14, 22 | -0.75 Increased by +93.48% | -1.87 Increased by +59.89% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 318.00 K Increased by +15.80 K% | 6.46 M Increased by +136.31% | Increased by +2.03 K% Increased by +100.23% |
| Mar 31, 24 | 542.00 K Increased by +27.00 K% | -4.19 M Increased by +80.97% | Decreased by -772.88% Increased by +99.93% |
| Dec 31, 23 | 0.00 Decreased by -100.00% | -15.41 M Decreased by -14.43% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -73.45 M Decreased by -393.84% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 2.00 K Decreased by -98.08% | -17.81 M Decreased by -196.93% | Decreased by -890.35 K% Decreased by -15.34 K% |
| Mar 31, 23 | 2.00 K Decreased by -98.13% | -22.02 M Decreased by -3.78 K% | Decreased by -1.10 M% Decreased by -196.75 K% |
| Dec 31, 22 | 14.00 K Decreased by -96.78% | -13.47 M Increased by +85.50% | Decreased by -96.21 K% Decreased by -350.61% |
| Sep 30, 22 | 80.00 K Decreased by -56.04% | -14.87 M Increased by +66.00% | Decreased by -18.59 K% Increased by +22.64% |